The Centers for Disease Control and Prevention recently announced its development of a new diagnostic test to detect the presence of the dengue virus.

This month, the Sabin Vaccine Institute will begin a Phase-1 clinical trial in Washington, DC to further investigate the Na-GST-1 human hookworm vaccine candidate.

Each year since 1994 the Sabin Vaccine Institute has  recognized distinguished members of the scientific community  with its highest honor, the Albert B. Sabin Gold Medal Award.  Gold Medal Award winners have made significant contributions  to vaccinology or a complementary field.

Dr. de Quadros and Hotez featured in Vaccine special supplement!

Pages